Skip to content
Whale Atlas — Follow the signal.
Home
FULL RECORDS
Search insider filingsAll Congress filings
MORE TOOLS
WatchlistGold IntelligencePeopleCharts & technicalsCompany financialsOfficial newsMy saved workspace
YOUR RESEARCH
HomeSearch insider filingsAll Congress filings
More research tools
ExploreGold IntelligencePeopleInvestigate an ideaCharts & technicalsMore evidenceCompany financialsOfficial newsMy research & helpWatchlistMy saved workspaceLearn the basicsHow signals workData & coverage
RESOURCES
LearnMethodologyData sources
Built on public evidence.

Primary sources. Clear reasoning.
No black boxes.

Our approach
Public research workspacev1.0

Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…

HomeSearchCongressWatchlist
© 2026 Whale AtlasFree public-filing research. Not financial advice. By using this site you agree to the Terms of Use.
FAQCompare trackersMethodologyData & correctionsTermsPrivacy
Back to Home
C

CVS

NYSE

CVS HEALTH Corp

Latest disclosureJune 29, 2026
Insider score Why 0?
0/ 100
Qualifying buys · 30d
$0

0 purchases · 9 sales

Price by TradingViewDelayed quote from TradingView, for viewing only. It does not power Whale Atlas scores or alerts. If the quote does not load, open the TradingView link.

Insider transactions 50

Limited filing history
All50Buying0Selling9Other41
Filters

Last 30 daysNo qualifying insider buying. No qualifying insider sales.

50 trades · March 31, 2026 – June 26, 2026Incomplete history: this shows the filings imported so far, not every filing ever made. Dates are trade dates. Filters affect this table only.

Showing the first 6 of 50 trades on this page.

Tax or exercise withholding

James David Clark

SVP, Cont & Chief Acct Officer

Common Stock (Restricted)

Value context
$41.3K
Reported price
$90.98 / share
Traded June 26, 2026Filed June 29, 2026SEC filing
Tax or exercise withholding

Brian Newman

EVP, Chief Financial Officer

Common Stock

Value context
$225.45K
Reported price
$90.98 / share
Traded May 31, 2026Filed June 1, 2026SEC filing
Explore furtherTechnical lab Company financials Test a strategy Compare company

Why this buying score?

No qualifying common-equity purchases

No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.

+0 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Source
SEC EDGAR · Form 4
Issuer CIK
0000064803
Latest public acceptance
Jun 29, 2026, 07:11 PM UTC
Score calculated
Oct 8, 2026, 12:03 AM UTC
Parser
form4-parser-1.5
Classifier
form4-classifier-1.1
Scoring methodology
insider-experimental-1.1
Availability
Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.

Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.

Tax or exercise withholding

Amy Compton-Phillips

EVP, Chief Medical Officer

Common Stock

Value context
$693.09K
Reported price
$90.98 / share
Traded May 31, 2026Filed June 1, 2026SEC filing
Other activity disclosed

Fernando Aguirre

Director

Common Stock

Value context
$2.85M
Reported price
$93.775 / share
Traded May 20, 2026Filed May 22, 2026SEC filing
Other activity disclosed

Fernando Aguirre

Director

Common Stock

Value context
$146.14K
Reported price
$93.501 / share
Traded May 21, 2026Filed May 22, 2026SEC filing
Sale disclosed

Larry Robbins

Director

Common Stock

Reported value
$187.33M
Reported price
$94.448 / share
Traded May 19, 2026Filed May 21, 2026SEC filing
Sale disclosed

Larry Robbins

Director

Common Stock

Reported value
$14.37K
Reported price
$95.18 / share
Traded May 19, 2026Filed May 21, 2026SEC filing
Sale disclosed

Larry Robbins

Director

Common Stock

Reported value
$74.56M
Reported price
$93.4766 / share
Traded May 20, 2026Filed May 21, 2026SEC filing
Sale disclosed

Larry Robbins

Director

Common Stock

Reported value
$14.48M
Reported price
$94.8061 / share
Traded May 20, 2026Filed May 21, 2026SEC filing
Sale disclosed

Larry Robbins

Director

Common Stock

Reported value
$6.4M
Reported price
$95.6655 / share
Traded May 20, 2026Filed May 21, 2026SEC filing
Sale disclosed

Larry Robbins

Director

Common Stock

Reported value
$77.03K
Reported price
$96.2819 / share
Traded May 20, 2026Filed May 21, 2026SEC filing
Sale disclosed

Larry Robbins

Director

Common Stock

Reported value
$34.62M
Reported price
$93.4482 / share
Traded May 21, 2026Filed May 21, 2026SEC filing
Sale disclosed

Larry Robbins

Director

Cash-Settled Swaps

Derivative security · not the ordinary share price.

Reported value
$35.27M
Reported price
$93.311 / derivative unit
Traded May 21, 2026Filed May 21, 2026SEC filing
Award disclosed

John E. Gallina

Director

Deferred Stock Units

Derivative security · not the ordinary share price.

Value context
$140.63K
Reported price
$97.15 / derivative unit
Traded May 14, 2026Filed May 15, 2026SEC filing
Award disclosed

Michael F. Mahoney

Director

Deferred Stock Units

Derivative security · not the ordinary share price.

Value context
$168.75K
Reported price
$97.15 / derivative unit
Traded May 14, 2026Filed May 15, 2026SEC filing
Award disclosed

Fernando Aguirre

Director

Common Stock

Value context
$151.85K
Reported price
$97.15 / share
Traded May 14, 2026Filed May 15, 2026SEC filing
Award disclosed

Jeffrey R. Balser

Director

Common Stock

Value context
$199.93K
Reported price
$97.15 / share
Traded May 14, 2026Filed May 15, 2026SEC filing
Award disclosed

J. Scott Kirby

Director

Common Stock

Value context
$140.58K
Reported price
$97.15 / share
Traded May 14, 2026Filed May 15, 2026SEC filing
Award disclosed

Leslie V. Norwalk

Director

Common Stock

Value context
$140.58K
Reported price
$97.15 / share
Traded May 14, 2026Filed May 15, 2026SEC filing
Award disclosed

Guy P. Sansone

Director

Common Stock

Value context
$140.58K
Reported price
$97.15 / share
Traded May 14, 2026Filed May 15, 2026SEC filing
Award disclosed

Alecia A. Decoudreaux

Director

Deferred Stock Units

Derivative security · not the ordinary share price.

Value context
$140.63K
Reported price
$97.15 / derivative unit
Traded May 14, 2026Filed May 15, 2026SEC filing
Award disclosed

Anne A. Finucane

Director

Deferred Stock Units

Derivative security · not the ordinary share price.

Value context
$150K
Reported price
$97.15 / derivative unit
Traded May 14, 2026Filed May 15, 2026SEC filing
Award disclosed

C. David Brown II

Director

Common Stock

Value context
$150K
Reported price
$97.15 / share
Traded May 14, 2026Filed May 15, 2026SEC filing
Award disclosed

Douglas H. Shulman

Director

Deferred Stock Units

Derivative security · not the ordinary share price.

Value context
$140.63K
Reported price
$97.15 / derivative unit
Traded May 14, 2026Filed May 15, 2026SEC filing
Award disclosed

Larry Robbins

Director

Deferred Stock Units

Derivative security · not the ordinary share price.

Value context
$187.5K
Reported price
$97.15 / derivative unit
Traded May 14, 2026Filed May 15, 2026SEC filing
Sale disclosed

Tilak Mandadi

EVP, Chief Exp & Tech Officer

Common Stock

Reported value
$6.23M
Reported price
$89.58 / share
Traded May 8, 2026Filed May 11, 2026SEC filing
Award disclosed

Prem S. Shah

EVP and Group President

Common Stock (Restricted)

Value context
$1.8M
Reported price
$71.82 / share
Traded March 31, 2026Filed April 2, 2026SEC filing
Tax or exercise withholding

Prem S. Shah

EVP and Group President

Common Stock

Value context
$107.58K
Reported price
$72.49 / share
Traded April 1, 2026Filed April 2, 2026SEC filing
Award disclosed

Prem S. Shah

EVP and Group President

Stock Option

Derivative security · not the ordinary share price.

Value context
$11.61M
Reported price
$71.82 / derivative unit
Traded March 31, 2026Filed April 2, 2026SEC filing
Award disclosed

Brian Newman

EVP, Chief Financial Officer

Common Stock (RSUs)

Derivative security · not the ordinary share price.

Value context
$1.4M
Reported price
$71.82 / derivative unit
Traded March 31, 2026Filed April 2, 2026SEC filing
Award disclosed

Brian Newman

EVP, Chief Financial Officer

Stock Option

Derivative security · not the ordinary share price.

Value context
$9.03M
Reported price
$71.82 / derivative unit
Traded March 31, 2026Filed April 2, 2026SEC filing
Award disclosed

Steven H. Nelson

EVP and President, Aetna

Common Stock (Restricted)

Value context
$1.6M
Reported price
$71.82 / share
Traded March 31, 2026Filed April 2, 2026SEC filing
Tax or exercise withholding

Steven H. Nelson

EVP and President, Aetna

Common Stock

Value context
$176.3K
Reported price
$72.49 / share
Traded April 1, 2026Filed April 2, 2026SEC filing
Award disclosed

Steven H. Nelson

EVP and President, Aetna

Stock Option

Derivative security · not the ordinary share price.

Value context
$10.32M
Reported price
$71.82 / derivative unit
Traded March 31, 2026Filed April 2, 2026SEC filing
Award disclosed

Tilak Mandadi

EVP, Chief Exp & Tech Officer

Common Stock (RSUs)

Derivative security · not the ordinary share price.

Value context
$1.6M
Reported price
$71.82 / derivative unit
Traded March 31, 2026Filed April 2, 2026SEC filing
Tax or exercise withholding

Tilak Mandadi

EVP, Chief Exp & Tech Officer

Common Stock

Value context
$263.43K
Reported price
$72.49 / share
Traded April 1, 2026Filed April 2, 2026SEC filing
Award disclosed

Tilak Mandadi

EVP, Chief Exp & Tech Officer

Stock Option

Derivative security · not the ordinary share price.

Value context
$10.32M
Reported price
$71.82 / derivative unit
Traded March 31, 2026Filed April 2, 2026SEC filing
Award disclosed

Samrat S. Khichi

EVP, CPO and General Counsel

Common Stock (Restricted)

Value context
$899.98K
Reported price
$71.82 / share
Traded March 31, 2026Filed April 2, 2026SEC filing
Tax or exercise withholding

Samrat S. Khichi

EVP, CPO and General Counsel

Common Stock

Value context
$256.69K
Reported price
$72.49 / share
Traded April 1, 2026Filed April 2, 2026SEC filing
Award disclosed

Samrat S. Khichi

EVP, CPO and General Counsel

Stock Option

Derivative security · not the ordinary share price.

Value context
$5.81M
Reported price
$71.82 / derivative unit
Traded March 31, 2026Filed April 2, 2026SEC filing
Award disclosed

J. David Joyner

President, CEO and Chair

Common Stock (RSUs)

Derivative security · not the ordinary share price.

Value context
$6.2M
Reported price
$71.82 / derivative unit
Traded March 31, 2026Filed April 2, 2026SEC filing
Tax or exercise withholding

J. David Joyner

President, CEO and Chair

Common Stock

Value context
$582.02K
Reported price
$72.49 / share
Traded April 1, 2026Filed April 2, 2026SEC filing
Award disclosed

Amy Compton-Phillips

EVP, Chief Medical Officer

Common Stock (RSUs)

Derivative security · not the ordinary share price.

Value context
$399.97K
Reported price
$71.82 / derivative unit
Traded March 31, 2026Filed April 2, 2026SEC filing
Award disclosed

Amy Compton-Phillips

EVP, Chief Medical Officer

Stock Option

Derivative security · not the ordinary share price.

Value context
$2.58M
Reported price
$71.82 / derivative unit
Traded March 31, 2026Filed April 2, 2026SEC filing
Award disclosed

James David Clark

SVP, Cont & Chief Acct Officer

Common Stock (Restricted)

Value context
$799.93K
Reported price
$71.82 / share
Traded March 31, 2026Filed April 2, 2026SEC filing
Tax or exercise withholding

James David Clark

SVP, Cont & Chief Acct Officer

Common Stock

Value context
$236.46K
Reported price
$72.49 / share
Traded April 1, 2026Filed April 2, 2026SEC filing
Award disclosed

James David Clark

SVP, Cont & Chief Acct Officer

Stock Option

Derivative security · not the ordinary share price.

Value context
$860.12K
Reported price
$71.82 / derivative unit
Traded March 31, 2026Filed April 2, 2026SEC filing
Award disclosed

Heidi B. Capozzi

EVP and Chief People Officer

Common Stock (Restricted)

Value context
$720K
Reported price
$71.82 / share
Traded March 31, 2026Filed April 2, 2026SEC filing
Tax or exercise withholding

Heidi B. Capozzi

EVP and Chief People Officer

Common Stock

Value context
$96.7K
Reported price
$72.49 / share
Traded April 1, 2026Filed April 2, 2026SEC filing
Award disclosed

Heidi B. Capozzi

EVP and Chief People Officer

Stock Option

Derivative security · not the ordinary share price.

Value context
$4.64M
Reported price
$71.82 / derivative unit
Traded March 31, 2026Filed April 2, 2026SEC filing
Reporting insiderSecurity / transactionAmount / priceValueTraded / disclosedSource
SVP, Cont & Chief Acct OfficerCommon Stock (Restricted)Exercise-price or tax withholding454$90.98 / share$41.3KJun 26Filed Jun 29 · 3d laterSEC filing
EVP, Chief Financial OfficerCommon StockExercise-price or tax withholding2,478$90.98 / share$225.45KMay 31Filed Jun 1 · 1d laterSEC filing
EVP, Chief Medical OfficerCommon StockExercise-price or tax withholding7,618$90.98 / share$693.09KMay 31Filed Jun 1 · 1d laterSEC filing
DirectorCommon StockDisposition to issuer30,437$93.78 / share$2.85MMay 20Filed May 22 · 2d laterSEC filing
DirectorCommon StockDisposition to issuer1,563$93.50 / share$146.14KMay 21Filed May 22 · 1d laterSEC filing
DirectorCommon StockSale2 trades1,983,538avg $94.45 / share$187.34MMay 19Filed May 21 · 2d later
2 filings
  • 1,983,387 @ $94.45 · $187.33MSEC filing
  • 151 @ $95.18 · $14.37KSEC filing
DirectorCommon StockSale4 trades1,018,000avg $93.82 / share$95.51MMay 20Filed May 21 · 1d later
4 filings
  • 797,628 @ $93.48 · $74.56MSEC filing
  • 152,691 @ $94.81 · $14.48MSEC filing
  • 66,881 @ $95.67 · $6.4MSEC filing
  • 800 @ $96.28 · $77.03KSEC filing
DirectorCommon StockSale370,462$93.45 / share$34.62MMay 21Filed May 21 · 0d laterSEC filing
DirectorCash-Settled SwapsSaleDerivative units378,000$93.31 / derivative unit$35.27MMay 21Filed May 21 · 0d laterSEC filing
DirectorDeferred Stock UnitsGrant or awardDerivative units1,448$97.15 / derivative unit$140.63KMay 14Filed May 15 · 1d laterSEC filing
DirectorDeferred Stock UnitsGrant or awardDerivative units1,737$97.15 / derivative unit$168.75KMay 14Filed May 15 · 1d laterSEC filing
DirectorCommon StockGrant or award1,563$97.15 / share$151.85KMay 14Filed May 15 · 1d laterSEC filing
DirectorCommon StockGrant or award2,058$97.15 / share$199.93KMay 14Filed May 15 · 1d laterSEC filing
DirectorCommon StockGrant or award1,447$97.15 / share$140.58KMay 14Filed May 15 · 1d laterSEC filing
DirectorCommon StockGrant or award1,447$97.15 / share$140.58KMay 14Filed May 15 · 1d laterSEC filing
DirectorCommon StockGrant or award1,447$97.15 / share$140.58KMay 14Filed May 15 · 1d laterSEC filing
DirectorDeferred Stock UnitsGrant or awardDerivative units1,448$97.15 / derivative unit$140.63KMay 14Filed May 15 · 1d laterSEC filing
DirectorDeferred Stock UnitsGrant or awardDerivative units1,544$97.15 / derivative unit$150KMay 14Filed May 15 · 1d laterSEC filing
DirectorCommon StockGrant or award1,544$97.15 / share$150KMay 14Filed May 15 · 1d laterSEC filing
DirectorDeferred Stock UnitsGrant or awardDerivative units1,448$97.15 / derivative unit$140.63KMay 14Filed May 15 · 1d laterSEC filing
DirectorDeferred Stock UnitsGrant or awardDerivative units1,930$97.15 / derivative unit$187.5KMay 14Filed May 15 · 1d laterSEC filing
EVP, Chief Exp & Tech OfficerCommon StockSale69,551$89.58 / share$6.23MMay 8Filed May 11 · 3d laterSEC filing
EVP and Group PresidentCommon Stock (Restricted)Grant or award25,062$71.82 / share$1.8MMar 31Filed Apr 2 · 2d laterSEC filing
EVP and Group PresidentCommon StockExercise-price or tax withholding1,484$72.49 / share$107.58KApr 1Filed Apr 2 · 1d laterSEC filing
EVP and Group PresidentStock OptionGrant or awardDerivative units161,676$71.82 / derivative unit$11.61MMar 31Filed Apr 2 · 2d laterSEC filing
EVP, Chief Financial OfficerCommon Stock (RSUs)Grant or awardDerivative units19,493$71.82 / derivative unit$1.4MMar 31Filed Apr 2 · 2d laterSEC filing
EVP, Chief Financial OfficerStock OptionGrant or awardDerivative units125,748$71.82 / derivative unit$9.03MMar 31Filed Apr 2 · 2d laterSEC filing
EVP and President, AetnaCommon Stock (Restricted)Grant or award22,277$71.82 / share$1.6MMar 31Filed Apr 2 · 2d laterSEC filing
EVP and President, AetnaCommon StockExercise-price or tax withholding2,432$72.49 / share$176.3KApr 1Filed Apr 2 · 1d laterSEC filing
EVP and President, AetnaStock OptionGrant or awardDerivative units143,712$71.82 / derivative unit$10.32MMar 31Filed Apr 2 · 2d laterSEC filing
EVP, Chief Exp & Tech OfficerCommon Stock (RSUs)Grant or awardDerivative units22,277$71.82 / derivative unit$1.6MMar 31Filed Apr 2 · 2d laterSEC filing
EVP, Chief Exp & Tech OfficerCommon StockExercise-price or tax withholding3,634$72.49 / share$263.43KApr 1Filed Apr 2 · 1d laterSEC filing
EVP, Chief Exp & Tech OfficerStock OptionGrant or awardDerivative units143,712$71.82 / derivative unit$10.32MMar 31Filed Apr 2 · 2d laterSEC filing
EVP, CPO and General CounselCommon Stock (Restricted)Grant or award12,531$71.82 / share$899.98KMar 31Filed Apr 2 · 2d laterSEC filing
EVP, CPO and General CounselCommon StockExercise-price or tax withholding3,541$72.49 / share$256.69KApr 1Filed Apr 2 · 1d laterSEC filing
EVP, CPO and General CounselStock OptionGrant or awardDerivative units80,838$71.82 / derivative unit$5.81MMar 31Filed Apr 2 · 2d laterSEC filing
President, CEO and ChairCommon Stock (RSUs)Grant or awardDerivative units86,326$71.82 / derivative unit$6.2MMar 31Filed Apr 2 · 2d laterSEC filing
President, CEO and ChairCommon StockExercise-price or tax withholding8,029$72.49 / share$582.02KApr 1Filed Apr 2 · 1d laterSEC filing
EVP, Chief Medical OfficerCommon Stock (RSUs)Grant or awardDerivative units5,569$71.82 / derivative unit$399.97KMar 31Filed Apr 2 · 2d laterSEC filing
EVP, Chief Medical OfficerStock OptionGrant or awardDerivative units35,928$71.82 / derivative unit$2.58MMar 31Filed Apr 2 · 2d laterSEC filing
SVP, Cont & Chief Acct OfficerCommon Stock (Restricted)Grant or award11,138$71.82 / share$799.93KMar 31Filed Apr 2 · 2d laterSEC filing
SVP, Cont & Chief Acct OfficerCommon StockExercise-price or tax withholding3,262$72.49 / share$236.46KApr 1Filed Apr 2 · 1d laterSEC filing
SVP, Cont & Chief Acct OfficerStock OptionGrant or awardDerivative units11,976$71.82 / derivative unit$860.12KMar 31Filed Apr 2 · 2d laterSEC filing
EVP and Chief People OfficerCommon Stock (Restricted)Grant or award10,025$71.82 / share$720KMar 31Filed Apr 2 · 2d laterSEC filing
EVP and Chief People OfficerCommon StockExercise-price or tax withholding1,334$72.49 / share$96.7KApr 1Filed Apr 2 · 1d laterSEC filing
EVP and Chief People OfficerStock OptionGrant or awardDerivative units64,670$71.82 / derivative unit$4.64MMar 31Filed Apr 2 · 2d laterSEC filing

Congress transactions 9

All Congress filings
Full sale disclosedAmended report

CVS Health Corporation Common Stock · Stock

The filing reports a full sale for a joint account.

Thomas H Tuberville official portraitThomas H TubervilleReporting Senate member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
August 26, 2024
Filed August 5, 2026 · 709d laterOriginal report
Purchase disclosed

CVS Health Corporation Common Stock · Stock

The filing reports a purchase for the member.

AAAlan ArmstrongReporting Senate member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
March 27, 2026
Filed July 21, 2026 · 116d laterOriginal report
Partial sale disclosedAmended report

CVS Health Corporation Common Stock (CVS) · Stock

The filing reports a partial sale for the member.

Dwight Evans official portraitDwight EvansReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
November 21, 2025
Filed May 15, 2026 · 175d laterOriginal report
Purchase disclosed

CVS Corp · Stock

The filing reports a purchase for a joint account.

John Boozman official portraitJohn BoozmanReporting Senate member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
January 29, 2026
Filed February 15, 2026 · 17d laterOriginal report
Sale disclosed

CVS Health Corporation Common Stock (CVS) · Stock

The filing reports a sale for the member.

Dwight Evans official portraitDwight EvansReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
November 21, 2025
Filed December 19, 2025 · 28d laterOriginal report
Sale disclosed

CVS Health Corporation Common Stock (CVS) · Stock

The filing reports a sale for a spouse.

Lisa McClain official portraitLisa McClainReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
October 31, 2025
Filed November 21, 2025 · 21d laterOriginal report
Purchase disclosed

CVS Health Corporation Common Stock (CVS) · Stock

The filing reports a purchase for a spouse.

Lisa McClain official portraitLisa McClainReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
October 30, 2025
Filed November 21, 2025 · 22d laterOriginal report
Sale disclosed

CVS Health Corporation Common Stock (CVS) · Stock

The filing reports a sale for a spouse.

Lisa McClain official portraitLisa McClainReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
October 30, 2025
Filed November 21, 2025 · 22d laterOriginal report
Sale disclosed

CVS Health Corporation Common Stock (CVS) · Stock

The filing reports a sale for a spouse.

Valerie Hoyle official portraitValerie HoyleReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
September 23, 2025
Filed October 10, 2025 · 17d laterOriginal report
Limited filing history · Market-wide discovery does not establish complete company history. View coverage